Evidence of NI-0101 pharmacological activity, an anti-TLR4 antibody, in a randomized phase I dose escalation study in healthy volunteers receiving LPS.
about
Evidence of NI-0101 pharmacological activity, an anti-TLR4 antibody, in a randomized phase I dose escalation study in healthy volunteers receiving LPS.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Evidence of NI-0101 pharmacolo ...... lthy volunteers receiving LPS.
@en
Evidence of NI-0101 pharmacolo ...... lthy volunteers receiving LPS.
@nl
type
label
Evidence of NI-0101 pharmacolo ...... lthy volunteers receiving LPS.
@en
Evidence of NI-0101 pharmacolo ...... lthy volunteers receiving LPS.
@nl
prefLabel
Evidence of NI-0101 pharmacolo ...... lthy volunteers receiving LPS.
@en
Evidence of NI-0101 pharmacolo ...... lthy volunteers receiving LPS.
@nl
P2093
P2860
P356
P1476
Evidence of NI-0101 pharmacolo ...... lthy volunteers receiving LPS.
@en
P2093
E van Poelgeest
J Burggraaf
K de Graaf
M Moerland
P2860
P304
P356
10.1002/CPT.522
P407
P577
2016-10-05T00:00:00Z